Objave tvrtki · 13. 11. 2026.1 min read
Leqembi® Pen subcutaneous treatment launched in Japan
Lokalni automatski prijevod · Izvorni jezik izvora
Summary
STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…
Izvorni jezik izvora: PR Newswire UK — News ReleasesOtvorite izvorno priopćenje →